CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy

BMC Cancer

Table 5 Relationship between serum tumor markers and pathological factors

		N stage		P value	ypTNM		P value	VOLI		P value
		N-	N+		I-II	III		+	–
pre-CA199	–	80	125	0.009	93	112	0.050	156	49	0.400
pre-CA199	+	15	54		22	47		49	20
pre-CA125	–	62	74	0.000	69	67	0.001	102	34	0.116
pre-CA125	+	6	46		12	40		33	19
pre-CA724	–	49	92	0.039	63	78	0.007	110	31	0.082
pre-CA724	+	18	65		22	61		56	27
post-CA199	–	81	133	0.003	100	114	0.003	159	55	0.559
post-CA199	+	3	26		5	24		23	6
post-CA125	–	44	44	0.001	49	39	0.014	65	23	0.854
post-CA125	+	22	62		31	53		61	23
post-CA724	–	45	69	0.022	53	61	0.098	91	23	0.019
post-CA724	+	17	56		25	48		47	26
diff-CA199	–	34	62	0.833	41	55	0.969	70	26	0.650
diff-CA199	+	46	89		58	77		102	33
diff-CA125	–	23	51	0.152	32	42	0.567	52	22	0.754
diff-CA125	+	31	42		35	38		53	20
diff-CA724	–	24	50	0.669	26	48	0.275	50	24	0.223
diff-CA724	+	27	65		40	52		70	22

ISSN: 1471-2407